National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

This is VAERS ID 1215192



Case Details

VAERS ID: 1215192 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-23
Onset:2021-01-04
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ1688/V0007 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Coma, Haemorrhagic stroke, Hypertension
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypertension (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-04
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: WARFARIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Multiple sclerosis (Taking medicines for multiple sclerosis); Thrombosis
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021391930

Write-up: Hypertension.; coma; Haemorrhagic stroke; This is a spontaneous report from a contactable consumer. This is a report received from the Agency Regulatory Authority. Regulatory authority report number: GB-MHRA-WEBCOVID-202104080925179560, Safety Report Unique Identifier: GB-MHRA-ADR 25101425. An 80-years-old male patient received first dose of BNT162B2, lot no. EJ1688/V0007, via an unspecified route of administration on 23Dec2020 as single dose for COVID-19 immunisation. Medical history included multiple sclerosis (taking medicines for multiple sclerosis) and thrombosis. He has not had symptoms associated with COVID-19, not had a COVID-19 test, and not enrolled in clinical trial. Concomitant medications included warfarin taken for thrombosis and unspecified medicines for multiple sclerosis. The patient experienced haemorrhagic stroke on 04Jan2021 (fatal per HA assessment). Case narrative: Taken to hospital and went into coma. Passed away from incebral haemorage and hypertension. Not unwell before vaccine. No relevant investigations or tests conducted. The patient died on 04Jan2021 due to haemorrhagic stroke and hypertension. The outcome of coma was unknown. It was not reported if an autopsy was performed. Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: Haemorrhagic stroke; Hypertension


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1215192

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166